Article info

Comparison of combination therapy with paclitaxel Taxol® and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study

Authors

  1. Address for correspondence: Dr W. P. McGuire, Division of Hematology/Oncology, Emory University, 1327 Clifton Road, Room 36192, Atlanta, GA 30322, USA.

Citation

McGuire WP, Hoskins WJ, Brady MF, et al
Comparison of combination therapy with paclitaxel Taxol® and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: a Gynecologic Oncology Group study

Publication history

  • First published September 1, 1996.
Online issue publication 
December 03, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.